GMED Globus Medical Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 97
Relative Strength: Rel. Strength: 34
Relative Valuation: Rel. Valuation: 80
Relative Profitability: Rel. Profitability: 89

EPS in 2025 (TTM): $2.63

Last Report Period Date: Jun 30, 2025

As of November 2025, according to Globus Medical's current financial statements, the company's 12-month EPS is $2.63. For the year 2024, the company recorded an earnings per share (EPS) of $0.76, which marks a drop compared to its EPS of $1.09 in 2023. Globus Medical's earnings per share for the quarterly report ending on Jun 30, 2025 reached $1.5.

GMED earnings history

Historical annual and quarterly earnings per share (EPS) data for Globus Medical
EPS (TTM)
$2.63
EPS Growth YoY (Quarterly)
552.2%
EPS (Quarterly)
$1.5
EPS Growth (Quarterly)
172.7%

The annual EPS for the year 2024 was $0.76, a drop of 30.3% from $1.09 in 2023. For the fiscal quarter that ended on Jun 30, 2025, the per-share earnings was $1.5, showing a 552.2% increase from the same quarter last year. For the twelve months ending June 2025, the EPS is $2.63. For the year 2023, the yearly earnings per share was $1.09, marking a decrease of 42.3% from 2022.

GMED EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
552.2%
EPS growth YoY
-30.3%
EPS growth 3Y avg
-19.9%
EPS growth 5Y avg
-13.5%

Globus Medical has registered an increase in EPS of 552.2% during the last 12 months (YoY, quarterly). In the last three years, GMED recorded an average annual EPS growth rate of -19.9%. Globus Medical had an average annual EPS growth rate of -13.5% during the last 5 years. Across the last decade, GMED had an average annual EPS growth of -2.5%.

GMED Earnings Waterfall

Breakdown of revenue, profit and net income for Globus Medical

GMED Earnings vs Peers

What are the earnings of GMED compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
GMED Globus Medical Inc 23.39 -30.3% -19.9% -13.5%
SYK Stryker Corp 46.33 -5.8% 14.1% 7.1%
OFIX Orthofix Medical Inc N/A 19.9% N/A N/A
ATEC Alphatec Holdings Inc N/A 26.6% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.